Trial intelligence / Profile preview

NORS in Tinea Pedis

NCT02871011Phase 2Completed

Start
Aug 2016
Primary completion
Nov 2016
Modality
DNA Intercalators/Alkylators, Inhalation Devices
Countries
1
01

Overview

A Phase 2 trial of nitric oxide in tinea pedis. Started Aug 2016; status: completed.

02

Drugs

nitric oxide
03

Conditions

tinea pedis

Beyond the preview

Go deeper on NCT02871011.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02871011.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call